US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
USOTC
IR BioSciences Holdings Inc New (CE) (IRBS)
IR BioSciences Holdings Inc New (CE) (IRBS) ニュース

IRBS

IR BioSciences (CE) (IRBS)

IR BioSciences Holdings Inc New (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IRBS

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2011/05/25	06 : 28	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2011/05/17	04 : 11	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2011/04/01	01 : 54	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2011/03/11	07 : 29	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/11/23	06 : 12	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/11/12	22 : 27	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/10/28	22 : 00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/10/02	05 : 37	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/09/08	20 : 00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/09/01	03 : 21	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/08/25	22 : 00	GlobeNewswire Inc.	University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/08/24	06 : 15	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/08/14	05 : 12	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/08/05	21 : 27	Marketwired	/ CORRECTION - ImmuneRegen BioSciences	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/08/04	20 : 00	Marketwired	ImmuneRegen BioSciences Completes Successful Reduction of Debt	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/07/26	19 : 01	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/05/25	04 : 40	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/05/18	00 : 51	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/05/01	06 : 17	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/04/27	21 : 00	Marketwired	ImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen Me	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/04/21	21 : 00	Marketwired	ImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead Indica	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/04/20	02 : 00	Marketwired	ImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/04/16	05 : 20	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/04/02	05 : 01	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/03/04	22 : 00	Marketwired	ImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary Fi	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/02/10	22 : 00	Marketwired	Fred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/01/27	22 : 00	Marketwired	National Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/01/27	04 : 54	Marketwired	IR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active Compound	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2010/01/05	22 : 00	Marketwired	ImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic Influenza	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
2009/12/24	22 : 00	Marketwired	ImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development Continues	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)

Showing the most relevant articles for your search:USOTC:IRBS

1 2 3 次へ >>

Blue Star Mobile

Vontobel Financial Produ...

Conafi Prestito

BNP Paribas Issuance

ScION Tech Growth II

Schwab US Broad Market

Otis Gallery (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約